EDGAR Filing Documents for 0001193125-16-602245

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001193125-16-602245

Filing Date

2016-05-25

Accepted

2016-05-25 16:03:04

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	d160912d424b5.htm	424B5	596906
2	GRAPHIC	g160912g57i48.jpg	GRAPHIC	22171
3	GRAPHIC	g160912g85y28.jpg	GRAPHIC	25703
	Complete submission text file	0001193125-16-602245.txt		664204

Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421

Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904

Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)